Literature DB >> 1541667

Immunoglobulin light chain variable region gene sequences for human antibodies to Haemophilus influenzae type b capsular polysaccharide are dominated by a limited number of V kappa and V lambda segments and VJ combinations.

E E Adderson1, P G Shackelford, R A Insel, A Quinn, P M Wilson, W L Carroll.   

Abstract

The immune repertoire to Haemophilus influenzae type b capsular polysaccharide (Hib PS) appears to be dominated by certain light chain variable region genes (IgVL). In order to examine the molecular basis underlying light chain bias, IgVL genes have been cloned from a panel of heterohybridomas secreting human anti-Hib PS (antibody) (anti-Hib PS Ab). One hybridoma, representative of the predominant serum clonotype of anti-Hib PS Ab in older children and adults following immunization or Hib infection, uses a V kappa II segment identical to the germline gene A2, and a JK3 segment. A second kappa hybridoma uses a member of the V kappa I family and a JK4 segment. Four lambda antibodies, all cross-reactive with the structurally related antigen Escherichia coli K100 PS, use V lambda VII segments which are 96-98% homologous to one another, and may originate from a single germline gene. Two additional lambda antibodies, not K100-cross-reactive, are encoded by members of the V lambda II family. All lambda antibodies use highly homologous J lambda 2 or J lambda 3 segments. The VJ joints of all lambda antibodies and the V kappa II-encoded antibody are notable for the presence of an arginine codon, suggesting an important role in antigen binding. Although more complex than heavy chain variable region gene usage, a significant portion of serum anti-Hib PS Ab is likely to be encoded by a limited number of V kappa and V lambda segments and VJ combinations, which may be selectively expressed during development, or following antigen exposure.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1541667      PMCID: PMC442915          DOI: 10.1172/JCI115649

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  49 in total

1.  Genetic recombination in a chromosomal translocation t(2;8)(p11;q24) of a Burkitt's lymphoma cell line, KOBK101.

Authors:  S Kato; K Tachibana; N Takayama; H Kataoka; M C Yoshida; T Takano
Journal:  Gene       Date:  1991-01-15       Impact factor: 3.688

2.  A major crossreactive idiotype associated with human antibodies to the Haemophilus influenzae b polysaccharide. Expression in relation to age and immunoglobulin G subclass.

Authors:  A H Lucas; D M Granoff
Journal:  J Clin Invest       Date:  1990-04       Impact factor: 14.808

3.  Clonal characterization of the human IgG antibody repertoire to Haemophilus influenzae type b polysaccharide. III. A single VKII gene and one of several JK genes are joined by an invariant arginine to form the most common L chain V region.

Authors:  M G Scott; D L Crimmins; D W McCourt; I Zocher; R Thiebe; H G Zachau; M H Nahm
Journal:  J Immunol       Date:  1989-12-15       Impact factor: 5.422

4.  First nucleotide sequence of a human immunoglobulin variable lambda gene belonging to subgroup II.

Authors:  F Brockly; D Alexandre; P Chuchana; S Huck; G Lefranc; M P Lefranc
Journal:  Nucleic Acids Res       Date:  1989-05-25       Impact factor: 16.971

5.  Antibody levels achieved in infants by course of Haemophilus influenzae type B polysaccharide/diphtheria toxoid conjugate vaccine.

Authors:  J Eskola; H Käyhty; H Peltola; V Karanko; P H Mäkelä; J Samuelson; L K Gordon
Journal:  Lancet       Date:  1985-05-25       Impact factor: 79.321

6.  Restricted Ig H chain V gene usage in the human antibody response to Haemophilus influenzae type b capsular polysaccharide.

Authors:  E E Adderson; P G Shackelford; A Quinn; W L Carroll
Journal:  J Immunol       Date:  1991-09-01       Impact factor: 5.422

7.  Induction of serum Haemophilus influenzae type B capsular antibodies in adult volunteers fed cross-reacting Escherichia coli 075:K100:H5.

Authors:  R Schneerson; J B Robbins
Journal:  N Engl J Med       Date:  1975-05-22       Impact factor: 91.245

8.  Clonal characterization of the human IgG antibody repertoire to Haemophilus influenzae type B polysaccharide. Demonstration of three types of V regions and their association with H and L chain isotypes.

Authors:  J J Tarrand; M G Scott; P A Takes; M H Nahm
Journal:  J Immunol       Date:  1989-04-01       Impact factor: 5.422

9.  Sequence homologies, N sequence insertion and JH gene utilization in VHDJH joining: implications for the joining mechanism and the ontogenetic timing of Ly1 B cell and B-CLL progenitor generation.

Authors:  H Gu; I Förster; K Rajewsky
Journal:  EMBO J       Date:  1990-07       Impact factor: 11.598

10.  Murine V kappa gene expression does not follow the VH paradigm.

Authors:  A Kaushik; D H Schulze; C Bona; G Kelsoe
Journal:  J Exp Med       Date:  1989-05-01       Impact factor: 14.307

View more
  27 in total

1.  Additive effect of neutralizing antibody and antiviral drug treatment in preventing virus escape and persistence.

Authors:  P Seiler; B M Senn; P Klenerman; U Kalinke; H Hengartner; R M Zinkernagel
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

2.  Structural requirements of the major protective antibody to Haemophilus influenzae type b.

Authors:  L Hougs; L Juul; A Svejgaard; T Barington
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

3.  Sequence analyses of three immunoglobulin G anti-virus antibodies reveal their utilization of autoantibody-related immunoglobulin Vh genes, but not V lambda genes.

Authors:  D F Huang; T Olee; Y Masuho; Y Matsumoto; D A Carson; P P Chen
Journal:  J Clin Invest       Date:  1992-12       Impact factor: 14.808

4.  VHDJH gene sequences and antigen reactivity of monoclonal antibodies produced by human B-1 cells: evidence for somatic selection.

Authors:  E W Schettino; S K Chai; M T Kasaian; H W Schroeder; P Casali
Journal:  J Immunol       Date:  1997-03-01       Impact factor: 5.422

5.  Polysaccharide binding potential of the human A2 or A18 kappa light chain homologues.

Authors:  D C Reason; T C Wagner; V R Tang; K D Moulton; A H Lucas
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

6.  Differential use of immunoglobulin light chain genes and B lymphocyte expansion at sites of disease in rheumatoid arthritis (RA) compared with circulating B lymphocytes.

Authors:  S P Moyes; R N Maini; R A Mageed
Journal:  Clin Exp Immunol       Date:  1998-08       Impact factor: 4.330

7.  Comparison of nonhuman primate antibodies against Haemophilus influenzae type b polysaccharide with human antibodies in oligoclonality and in vivo protective potency.

Authors:  K H Kim; M K Park; C C Peeters; J T Poolman; M H Shearer; R C Kennedy; M H Nahm
Journal:  Infect Immun       Date:  1994-06       Impact factor: 3.441

8.  Variable region sequences and idiotypic expression of a protective human immunoglobulin M antibody to capsular polysaccharides of Neisseria meningitidis group B and Escherichia coli K1.

Authors:  F H Azmi; A H Lucas; H V Raff; D M Granoff
Journal:  Infect Immun       Date:  1994-05       Impact factor: 3.441

9.  Molecular analysis of the human immunoglobulin V lambda II gene family.

Authors:  M Irigoyen; A Manheimer-Lory; B Gaynor; B Diamond
Journal:  J Clin Invest       Date:  1994-08       Impact factor: 14.808

10.  Protective and nonprotective human immunoglobulin M monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan manifest different specificities and gene use profiles.

Authors:  Robert W Maitta; Kausik Datta; Qing Chang; Robin X Luo; Bradley Witover; Krishanthi Subramaniam; Liise-anne Pirofski
Journal:  Infect Immun       Date:  2004-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.